These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 6686326)

  • 1. Comparison of propranolol and propranolol LA in hypertension using 24-hr noninvasive blood pressure monitoring.
    Rustin MH; Coomes EN
    Postgrad Med J; 1983 Dec; 59(698):770-4. PubMed ID: 6686326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Propranolol LA and ambulatory blood pressure.
    Mann S; Craig MW; Balasubramanian V; Raftery EB
    Br J Clin Pharmacol; 1980 Nov; 10(5):443-7. PubMed ID: 7437256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of long-acting propranolol on blood pressure and heart rate in hypertensive Chinese.
    Oh VM; Chia BL; Taylor EA
    Br J Clin Pharmacol; 1985 Aug; 20(2):144-7. PubMed ID: 4041332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ambulatory blood pressure during once-daily randomised double-blind administration of atenolol, metoprolol, pindolol, and slow-release propranolol.
    Floras JS; Jones JV; Hassan MO; Sleight P
    Br Med J (Clin Res Ed); 1982 Nov; 285(6352):1387-92. PubMed ID: 6814568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pharmacodynamics and pharmacokinetics of conventional and long-acting propranolol in patients with moderate hypertension.
    Serlin MJ; Orme ML; MacIver M; Green GJ; Sibeon RG; Breckenridge AM
    Br J Clin Pharmacol; 1983 May; 15(5):519-27. PubMed ID: 6860527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of a once daily long-acting formulation of propranolol with conventional propranolol given twice daily in patients with mild to moderate hypertension.
    Douglas-Jones AP
    J Int Med Res; 1979; 7(3):221-3. PubMed ID: 378731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Evening Bromazepam Administration on Blood Pressure and Heart Rate in Mild Hypertensive Patients.
    Costa A; Bosone D; Cotta Ramusino M; Perini G; Ghiotto N; Zoppi A; D Apos Angelo A; Fogari R
    Pharmacology; 2019; 104(1-2):1-6. PubMed ID: 30943497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of a long-acting form of propranolol and conventional propranolol in the treatment of hypertension in elderly patients.
    Khan AU
    J Int Med Res; 1987; 15(3):128-33. PubMed ID: 3301452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ketanserin versus propranolol in the treatment of mild and moderate essential hypertension: corroboration with ambulatory blood pressure monitoring.
    Novo S; Alaimo G; Giordano U; Raineri A; Strano A
    J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S104-6. PubMed ID: 2446055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The influence of a long-acting formulation of propranolol on the circadian rhythm of heart rate in elderly patients with essential hypertension].
    Shimamoto Y; Nakamura H; Shimamoto H; Sakata S
    Kokyu To Junkan; 1988 Nov; 36(11):1205-10. PubMed ID: 3247537
    [No Abstract]   [Full Text] [Related]  

  • 11. [Evaluation of the effectiveness of delayed-action propranolol in the treatment of arterial hypertension].
    Markiewicz M; Koziara Z; Wysokiński A; Lakomski B
    Wiad Lek; 1992 Apr; 45(7-8):243-7. PubMed ID: 1462581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of long-acting propranolol ('Inderal' LA) in the management of elderly hypertensive patients.
    Hamdy C; Tovey D; Baber NS; McAinsh J
    Eur J Clin Pharmacol; 1982; 22(5):379-81. PubMed ID: 7117349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Once-daily propranolol for hypertension: a comparison of regular-release, long-acting, and generic formulations.
    Carter BL; Gersema LM; Williams GO; Schabold K
    Pharmacotherapy; 1989; 9(1):17-22. PubMed ID: 2646619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Verapamil SR and propranolol LA: a comparison of efficacy and side effects in the treatment of mild to moderate hypertension.
    Bochsler JA; Simmons RL; Ward PJ; Chester PC; Latham AN
    J Hum Hypertens; 1988 Mar; 1(4):305-10. PubMed ID: 3065507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Propranolol in cardiac arrhythmias: a comparative study of the conventional and long-acting formulations.
    Kubik MM; Gill B; Dawes PM
    Curr Med Res Opin; 1986; 10(4):215-20. PubMed ID: 3780285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Twice-daily verapamil for hypertension: a comparison with propranolol.
    Hornung RS; Jones RI; Gould BA; Sonecha T; Raftery EB
    Am J Cardiol; 1986 Feb; 57(7):93D-98D. PubMed ID: 3513519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influences of propranolol and atenolol on the circadian rhythm of heart rate in elderly patients with essential hypertension.
    Shimamoto H; Shimamoto Y; Sakata S
    Clin Sci (Lond); 1990 Apr; 78(4):403-7. PubMed ID: 2160358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An assessment of Half-Inderal LA and Inderal LA in the treatment of hypertension in elderly subjects.
    Datta SR
    Br J Clin Pract; 1989 Mar; 43(3):102-8. PubMed ID: 2692687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single dose administration of propranolol in hypertension: a comparison of two formulations using clinic and home blood pressure measurements.
    Vandongen R; Beilin LJ; Lalor C; Wall BP
    Aust N Z J Med; 1982 Oct; 12(5):473-7. PubMed ID: 6758744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 24-hour noninvasive oscillometric blood pressure monitoring: evaluation of the antihypertensive circadian profile of nitrendipine.
    Meyer-Sabellek W; Schulte KL; Streitberg B; Gotzen R; Distler A
    J Cardiovasc Pharmacol; 1988; 12 Suppl 4():S22-8. PubMed ID: 2468870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.